SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-19-006726
Filing Date
2019-08-01
Accepted
2019-08-01 06:17:36
Documents
75
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 f6-k.htm 6-K 34690
2 ex-99d1.htm EX-99.1 157668
3 ex-99d2.htm EX-99.2 1246857
10 ex-99d1g001.jpg GRAPHIC 2420
  Complete submission text file 0001558370-19-006726.txt   5868846

Data Files

Seq Description Document Type Size
4 argx-20190630.xml EX-101.INS 1295685
5 argx-20190630.xsd EX-101.SCH 69396
6 argx-20190630_cal.xml EX-101.CAL 54055
7 argx-20190630_def.xml EX-101.DEF 132886
8 argx-20190630_lab.xml EX-101.LAB 426060
9 argx-20190630_pre.xml EX-101.PRE 287603
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 19990787
SIC: 2836 Biological Products, (No Diagnostic Substances)